Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, November 2, 2010

Hepatitis C: Drug Companies and Doctors get greedy;The Hedge Fund


A French doctor who worked as a consultant for Human Genome Sciences Inc. has been charged by the U.S. with insider-trading for allegedly tipping off a hedge fund about negative results of Albuferon drug trials.
.
Dr. Yves Benhamou, 50, of France, was arrested today on two federal charges filed by prosecutors in the office of Manhattan U.S. Attorney Preet Bharara, the FBI in New York said. Human Genome Sciences, or HGSI, is a developer of gene-based drugs.

Yesterday in the news :Roche Two Fines/One For Pegasys:Monies Paid To Nurse/Health Service To Use Drug

On Oct 26 ; HCV: A New Drug Enterprise For The Convicted Sam Waksal ?


No comments:

Post a Comment